MGMA joining Denver innovation hub

Beth Walsh | | Health Exec | Precision Medicine

The Medical Group Management Association (MGMA) will be one of the tenants of a new healthcare technology hub in Denver.

The Catalyst Health-Tech Innovation development will include other health-focused organizations, practice groups, health finance companies and high-tech organizations.

MGMA, which represents more than 33,000 medical practice leaders, is headquartered in Englewood, Colo., and the 5,000-square-foot addition to its existing campus will be part of the Catalyst Health-Tech Innovation development.

The additional space will provide an environment for MGMA staff and leaders to collaborate with other industry leaders on developing efficient and cost-effective strategies for medical practices and improving care for patients, said MGMA President and CEO Halee Fischer-Wright, MD, in a statement.

The hub is scheduled to open in 2018.

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.